| Trial ID: | L5066 |
| Source ID: | NCT00321321
|
| Associated Drug: |
Sulfonylurea
|
| Title: |
The Beta Cell Responsiveness to Glucose-dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00321321/results
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Sulfonylurea
|
| Outcome Measures: |
Primary: Insulin Secretion, area under the curve AUC and insulin secretion rate, 0 - 90 minutes |
|
| Sponsor/Collaborators: |
Sponsor: University Hospital, Gentofte, Copenhagen
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
12
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
|
| Start Date: |
2006-05
|
| Completion Date: |
2007-04
|
| Results First Posted: |
2008-10-02
|
| Last Update Posted: |
2015-07-16
|
| Locations: |
Department of Internal Medicine, Gentofte University Hospital, Hellerup, Copenhagen, 2900, Denmark
|
| URL: |
https://clinicaltrials.gov/show/NCT00321321
|
